ALTRAZEAL

TRANSFORMING POWDER DRESSING | TRANSFORMING TECHNOLOGY | TRANSFORMING WOUND CARE | TRANSFORMING LIVES

Altrazeal® is a patented powder dressing specially engineered to cover and protect the wound and to provide an ideal moist wound healing environment that supports cellular function and tissue repair. Its non-resorbable, sterile granules aggregate when hydrated with saline to form a moist, flexible, oxygen permeable film that fits and seals the wound. Powder may be added from time to time and secured with simple secondary dressings for more exudative wounds, without requiring primary dressing changes. As the wound heals, the powder dries and flakes off like a scab. Disclaimer: Please see the Altrazeal Instructions for Use for a complete listing of uses, warnings and precautions.

12/19/2025

TRAUMATIC WOUND WITH NECROTIZING FASCIITIS: CLINICIAN TESTIMONIAL

Altrazeal was used successfully for the treatment of a complex, infected traumatic wound with necrotizing fasciitis.

The patient was being treated by Dr. Jagan Mohan, who is dedicated to treating patients from underserved communities. Over time, the patient ran out of funds to continue his treatment, while still bearing a painful and infected wound. Fortunately, a member of our team, Vijay SK, was made aware of this situation and supplied Altrazeal on a charitable basis.

Thank you Dr. Jagan Mohan for treating Mr. Sharma and creating this video to share a novel method for treating complex traumatic wounds.

The Altrazeal team is truly blessed with people who are on a mission to !

12/15/2025

DIFFICULT TO HEAL PILONIDAL CYSTS: CLINICIAN TESTIMONIAL

Ann Marie Nie shares her experience with Altrazeal in treating chronic pilonidal cysts. Altrazeal filled and protected cavities in challenging locations, creating an environment conducive to healing, and accelerating wound closure while reducing dressing changes and enhancing patient comfort.

Thank you Ann Marie for believing in Altrazeal and joining our mission to

.

11/28/2025

Team Altrazeal wishes you a very Happy Thanksgiving!

11/19/2025

DATA RELEASE: COMBAT WOUNDS IN WAR ZONES

Our CEO, Vaidehi Shah, presented a case series at the 2025 Military Health System Research Symposium (MHSRS) meeting, on the use of Altrazeal in treating acute traumatic combat wounds in Ukraine.

Key Findings:

✅ ~88% fewer dressing changes
✅ Reduced pain related to dressing changes
✅ Complete wound closure
✅ Faster than expected return to duty

These results highlight how prolonged-wear TPD can conserve resources, ease the burden of care, and improve patient comfort in combat and resource-limited civilian settings.

Thank you, Dr. Rostyslav Bublii, MD, Michael Samotowka, MD, FACS, FCCP, FCCM, and jonathan saxe, MD, MAR, MBA, for believing in Altrazeal to heal your patients.

11/11/2025

We salute our heroes for their unwavering courage and service. Today and every day, we honor you.

11/06/2025

CLINICIAN TESTIMONIAL: Neonatal Wound Care

Rosalyn Barnabee, BSN, CWON and Tammy Lichtman, BSN, CWON, talk about their experience with Altrazeal in managing peristomal wounds and a mucus fistula after omphalocele repair in a 2-month-old infant.

✅ Improved wound healing with full epithelialization in 16 days
✅ Resolved moisture-associated skin damage (MASD) and tachycardia
✅ Reduced dressing changes and enhanced patient comfort

By providing a protective barrier and minimizing trauma from frequent dressing changes, Altrazeal enabled effective wound management and a suitable pouching solution for this complex neonatal case.

10/29/2025

Data Release: Peristomal Skin Complications and Stoma Erosion

Sona Raphi, RN, BSN, CWON, presented a compelling case study on using Altrazeal to manage complex peristomal skin complications with stoma erosion at the Dallas VA Medical Center.

Key Case Highlights:
• Reduced dressing changes
• Complete epithelialization achieved in 66 days
• No adverse events, no recurrence at 4-month follow-up

These results underscore Altrazeal’s potential to support more efficient wound management.

Kudos to frontline nurses like Sona for bringing these real-world outcomes to light!

10/22/2025

🚨 BREAKING NEWS: Military Medicine Journal Publication

A recent peer-reviewed publication highlights how Altrazeal can transform patient care, especially in resource constrained environments.

Key findings from a mission-oriented study in traumatic wounds:

- 51% median wound area reduction in 16 days
- 75% fewer dressing changes
- ⁠⁠All patients healed, experienced wound area reduction before discharge or were successfully grafted
- No adverse events

These results underscore Altrazeal’s potential to support more efficient wound management.

👉 Read the full article in Military Medicine: https://doi.org/10.1093/milmed/usaf250

Authors: Susan Rolniak St. John, MSN, APRN-NP; jonathan saxe, MD, FACS, MBA, MAR

Austrian Development Agency

10/16/2025

A proud moment for the A-Team!

Yesterday, Altrazeal lit up the Nasdaq Tower in Times Square, standing alongside 63 other incredible innovators from the 2025 MedTech Innovator cohort — marking the culmination of this year’s accelerator journey.

We’re deeply grateful for the community and support that’s driving groundbreaking innovation across the world. This is an unforgettable milestone on our mission to reimagine wound care and bring better healing solutions to patients everywhere.

10/12/2025

Tweesha Shah proudly represented our CEO, Vaidehi Shah, at the MedTech Innovator (MTI) Showcase Panel, alongside Fiona Simpson (BioMimir), Melissa Krebs, Ph.D. (GelSana), and Westbrook Weaver (Tempo Therapeutics).

A special thank you to Skander Limem, Ph.D., Director of Innovation, Surgery R&D at Becton, Dickinson and Company, for moderating the discussion, and Nicole Black, PhD from MTI for the incredible support behind the scenes.

And a big shout-out to Paul Grand, CEO, and Kathryn Zavala, COO, of for MedTech Innovator, for hosting The MedTech Conference sponsored by AdvaMed and creating a platform that connects groundbreaking technologies with investors and industry leaders.

10/06/2025

DATA RELEASE: COMPLEX PAINFUL NECK WOUND

At Symposium on Advanced Wound Care (SAWC) Fall 2025 meeting, Nancy Bernard, RN, BSN, CWON, and Rosemarie Machan, RN, BS, CWOCN (AdventHealth System, Orlando, FL) presented a case study on the use of Altrazeal® for a complex surgical neck wound.

✨ Key outcomes included:

- Complete wound closure
- Reduced dressing changes
- No dressing associated pain or pain medications required
- Simplified care post-discharge

This case highlights how Altrazeal can simplify wound management in anatomically challenging areas while improving patient comfort and reducing resource utilization .

09/17/2025

DATA RELEASE: ALTRAZEAL IN SICKLE CELL ASSOCIATED WOUNDS

Sickle cell associated wounds are notoriously difficult to heal as the treatment involves various challenges including pain, inflammation, chronicity and vascular insufficiency. At the Symposium on Advanced Wound Care (SAWC) Spring 2023 Meeting, Alisha Oropallo, MD and Amit Rao, MD from Northwell Health presented a case series illustrating the use of Altrazeal in sickle cell ulcers.

The study concluded that the implementation of Altrazeal showed significant improvement in the healing trajectory for both patients within a short period of time. The patients also reported reduced pain post-treatment.

To learn more about Altrazeal, click here: www.altrazeal.com

Address

4410 Beltway Drive
Addison, TX
75001

Telephone

+12149055145

Website

http://www.altrazeal.info/

Alerts

Be the first to know and let us send you an email when ALTRAZEAL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ALTRAZEAL:

Shortcuts

Featured

Psych Dimensions

Want your practice to be the top-listed Clinic in Addison?